🔎 Trials Near Me

Gara Jalqabaatti › Fibrolamellar hepatocellular carcinoma › Maryland › Baltimore

Qorannoo klinikaalii Fibrolamellar hepatocellular carcinoma Baltimore, MD keessatti

Qorannoo 3 Fibrolamellar hepatocellular carcinoma f Baltimore fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

Namoota walitti qabaa jiraSadarkaa 1
  • Johns Hopkins SKCCC, Baltimore
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07430202

DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Johns Hopkins SKCCC, Baltimore
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 12-Gur-2026 · NCT06027086

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

Namoota walitti qabaa jiraSadarkaa 1
  • Sidney Kimmel Comprehensive Cancer Center, Baltimore
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 03-Mud-2025 · NCT04248569

Qorannoo biroo Baltimore keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.